IDD Daily Updates and Restructuring Alert Weekly Updates, our email alerts
Leerink Further Adds To I-Banking Group
Healthcare and M&A among areas where firm is bulking up.
June 19, 2008
Continuing its expansion, Leerink Swann has made hires in its investment banking business in the mergers and acquisitions and corporate finance groups.
The healthcare-focused investment bank hired Adam Berger as a managing director and head of M&A and Daniel Lepanto joined as managing director in the M&A group. Marc Grasso will head West coast investment banking and work in the corporate finance group.
Berger was recently a managing director and head of healthcare M&A at Citigroup, where he worked for 17 years, originally joining Salomon Brothers. Throughout his career, he advised on more than 125 transactions totaling almost $400 billion.
Lepanto worked at Cowen & Co. as a managing director for the past 10 years. He has executed a wide range of mergers, acquisitions and other strategic advisory transactions. Prior to Cowen, he held positions at UBS and Wasserstein Perella.
Grasso joined from Morgan Stanley, where he worked 10 years as an executive director in the healthcare group. He was focused on capital raising and strategic advisory services for leading biotechnology, pharmaceutical and various healthcare companies. Prior to Morgan Stanley, he worked at Credit Suisse First Boston as a vice president in the healthcare group.
Leerink made additional hires earlier this month of two former Bear Stearns employees, Frederick Wise and Jason Gurda. Wise, who worked at Bear for 22 years, joined Leerink as a managing director covering the medical supplies and devices industry. Two of Wise’s associates, Danielle Antalffy and Miroslave Minkova, joined Leerink as well. Gurda worked at Bear for six years and joined Leerink as a director covering the healthcare facilities industry.
For more information on related topics, visit the following:
